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Attention deficit hyperactivity disorder
(ADHD) is one of the most common child-
hood psychiatric disorders, characterized by
developmentally inappropriate levels of inat-
tention, impulsivity, and hyperactivity
[American Psychiatric Association (APA)
2000; Biederman and Faraone 2005; Rappley
2005; Remschmidt 2005]. Prevalence of
ADHD in children has been reported to be
3–8% worldwide (Froehlich et al. 2007;
Leung et al. 1996; Remschmidt 2005).
Children who have ADHD are at increased
risk for conduct disorder, antisocial behavior,
and drug abuse later in life (Satterﬁeld et al.
2007). Moreover, the costs associated with
their medical care and education are substan-
tial (Leibson et al. 2001).
Although the causes of ADHD remain
unclear, both genetic and environmental fac-
tors are thought to influence the etiology of
ADHD (Banerjee et al. 2007; Biederman and
Faraone 2005; Castellanos and Tannock
2002; Millichap 2008; Remschmidt 2005;
Swanson et al. 2007). Family, twin, and
adoption studies have demonstrated high her-
itability, and various polymorphisms of
dopamine-related genes have been found to
increase susceptibility to ADHD (Castellanos
and Tannock 2002; Durston 2003; Khan
and Faraone 2006). Furthermore, many envi-
ronmental risk factors and potential gene–
environment interactions have also been
shown to increase the risk for the disorder
(Banerjee et al. 2007; Biederman and Faraone
2005; Millichap 2008; Thapar et al. 2007).
Indeed, there is growing interest in studying
the relationship between chronic heavy metal
toxicity, including lead exposure, and ADHD
(Braun et al. 2006; Konofal and Cortese
2007; Millichap 2008; Nigg et al. 2008).
Lead is one of the well-established environ-
mental poisons, and its general toxic effects,
particularly in children, continue to be a major
public health issue worldwide [American
Academy of Pediatrics (AAP) 2005; Lidsky
and Schneider 2003; Needleman 2004]. It is
well known that lead can cause cognitive
impairment and correlate with decreased IQ
scores and impaired attention (Canﬁeld et al.
2003; Koller et al. 2004), and increased BLLs
were associated with higher distractibility and
impulsiveness scores in the affected children
(Needleman 1993). The World Health
Organization (WHO) and the U.S. Centers
for Disease Control and Prevention (CDC)
recommended that child blood lead levels
(BLLs) not exceed 10 µg/dL (CDC 1991;
WHO 1995). As a result of rapid industrializa-
tion in China, it is estimated that tens of mil-
lions of children 1–18 years of age have BLLs
≥ 10 µg/dL (Huo et al. 2007; Ren et al. 2006;
Wang and Zhang 2006). Furthermore, several
recent studies have shown that cognitive
deficits and behavioral problems in children
still exist even with BLLs < 10 µg/dL (Binns
et al. 2007; Braun et al. 2006; Canﬁeld et al.
2003; Koller et al. 2004). 
Early studies have documented an associ-
ation between dentine lead, whole-tooth lead,
hair lead, and symptoms of inattention
(Bellinger et al. 1994a, 1994b; Fergusson
et al. 1993; Needleman and Leviton 1979;
Needleman et al. 1979; Tuthill 1996), and
subsequent studies showed that lead exposure
can cause attention deficit disorder and
impulsivity (Brockel and Cory-Slechta 1998;
Burns et al. 1999; Eppright et al. 1997; Kahn
et al. 1995; Minder et al. 1994; Silva et al.
1988; Thomson et al. 1989; Wasserman et al.
1998, 2001). However, these studies may not
be conclusive. First, few studies have investi-
gated the effect of lead exposure on ADHD
formally diagnosed with the established crite-
ria in International Classification of Diseases,
10th Revision (ICD-10) (WHO 2007) or in
Diagnostic and Statistical Manual of Mental
Disorders, 4th ed., revised (DSM-IV-R; APA
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BACKGROUND: Attention deﬁcit/hyperactivity disorder (ADHD) and lead exposure are high-prevalence
conditions among children. 
OBJECTIVE: Our goal was to investigate the association between ADHD and blood lead levels
(BLLs) in Chinese children, adjusting for known ADHD risk factors and potential confounding
variables. 
METHODS: We conducted a pair-matching case–control study with 630 ADHD cases and 630 non-
ADHD controls 4–12 years of age, matched on the same age, sex, and socioeconomic status. The
case and control children were systematically evaluated via structured diagnostic interviews, includ-
ing caregiver interviews, based on the Diagnostic and Statistical Manual of Mental Disorders, 4th
ed., revised criteria (DSM-IV-R). We evaluated the association between BLLs and ADHD using the
Pearson chi-square test for categorical variables and the Student t-test for continuous data. We then
performed conditional multiple variables logistic regression analyses with backward stepwise selec-
tion to predict risk factors for ADHD. 
RESULTS: There was a signiﬁcant difference in BLLs between ADHD cases and controls. ADHD
cases were more likely to have been exposed to lead during childhood than the non-ADHD control
subjects, with adjustment for other known risk factors [children with BLLs ≥ 10 µg/dL vs.
≤ 5 µg/dL; OR = 6.0; 95% confidence interval (CI) = 4.10–8.77, p < 0.01; 5–10 µg/dL vs.
≤ 5 µg/dL, OR = 4.9; 95% CI = 3.47–6.98, p < 0.01]. These results were not modiﬁed by age and
sex variables. 
CONCLUSIONS: This was the largest sample size case–control study to date to study the association
between BLLs and ADHD in Chinese children. ADHD may be an additional deleterious outcome
of lead exposure during childhood, even when BLLs are < 10 µg/dL.
KEY WORDS: attention deﬁcit hyperactivity disorder, blood lead levels, case–control study. Environ
Health Perspect 116:1401–1406 (2008). doi:10.1289/ehp.11400 available via http://dx.doi.org/
[Online 5 June 2008]2000) (Burns et al. 1999; Eppright et al.
1997; Silva et al. 1988). Second, most studies
were limited by small sample size, and some
studies lacked sufﬁcient control of confound-
ing factors (Bellinger et al. 1994b; Minder
et al. 1994). Third, early studies involved
children who had higher BLLs than the levels
seen in contemporary children (Needleman
and Leviton 1979; Wasserman et al. 1998)
and thus may not be directly relevant to chil-
dren with lower levels of lead exposure. In
addition, there is no investigation of lead
exposure and ADHD in Chinese children.
Therefore, in an effort to evaluate the asso-
ciation between BLLs and the risk for ADHD
in Chinese children, we performed a case–
control study involving large samples of chil-
dren 4–12 years of age. We also considered
known potential variables in the etiology of
ADHD, such as delivery characteristics, peri-
natal factors, parental psychosocial factors, and
prenatal exposure to tobacco and alcohol. 
Methods
Subjects. This study was designed as a pair-
matching case–control study. ADHD subjects
were consecutively recruited from children
coming for initial or follow-up assessment from
October 2003 to August 2007 in two pediatric
clinics at the Anhui Provincial Children’s
Hospital and the Institute of Anhui Traditional
Chinese Medicine in Anhui Province, People’s
Republic of China. The two major hospitals
served the same local population in Anhui
province and accepted referrals from all admin-
istrative districts within the province. 
All ADHD (ICD-10 codes F90, 208–210)
subjects were children of Chinese Han nation-
ality 4–12 years of age at the time of investiga-
tion and had a lifetime medical history that
fully met the DSM-IV-R criteria (APA 2000;
Su et al. 2001) for ADHD. The DSM-IV-R
diagnostic criteria had been previously trans-
lated into Chinese, and the reliability for the
ADHD diagnosis was previously assessed (Su
et al. 2001).
The diagnoses of ADHD were derived
from a structured diagnostic interview based
on Schedule for Affective Disorders and
Schizophrenia for School-Age Children
(K-SADS-E) (Ambrosini 2000), which was
modified to assess DSM-IV-R criteria and
incorporate parents’ and teachers’ reports of
behavioral symptoms, clinical observation of
behavior, the Aberrant Behavior Checklist
(Aman and Singh 1986), and tests of attention
such as the Conners’ Continuous Performance
Test (Homack and Riccio 2006). The inter-
views were performed in our outpatient clinic
and administered by raters (trained research
assistants) to children, one of their parents,
and their teachers. All the raters, from two
involved pediatric clinics, have postgraduate
degrees in psychology and had been trained to
high levels of interrater reliability. We com-
puted κ coefﬁcients of agreement between all
the raters and three experienced board-certi-
ﬁed child psychiatrists who listened to audio
taped interviews made by the raters. Based on
120 interviews, the median κ was 0.87; κ was
0.95 for ADHD. Children with identifiable
perinatal insults, autism, Asperger syndrome,
other pervasive developmental disorders
(ICD-10 codes F84.0–F84.9, 308.0), and
mental retardation (ICD-10 codes F70–F79,
312–315) were excluded.
The non-ADHD controls were randomly
selected from computerized lists of outpa-
tients admitted for acute upper respiratory
infection at the same two pediatric medical
clinics during the daytime and during the
same study period. By the pair-matched
design, each ADHD case and control set had
the same sex, the same age (difference
between birthdays within 6 months), and
almost the same level of socioeconomic status
(SES). The controls were given the same full
diagnostic assessment as the ADHD cases and
screened only for the absence of ADHD with-
out exclusion of any other diagnosis except
for the same exclusion criteria applied to
cases. SES is measured by poverty-to-income
ratio (PIR), and PIR is the ratio of family
income to the poverty threshold for the year
of the interview. Low SES was deﬁned as hav-
ing PIR values < 1 in our analysis and high
SES as having PIR > 3. The others were
regarded as middle SES. The study was
approved by our institutional review boards
and complied with all applicable require-
ments of the United States. The parents of all
the children in this study provided written
informed consent at enrollment.
Blood sampling and analysis. Blood sam-
ples (2 mL/child) were collected in heparinized
syringes. Lead concentrations were measured
by anodic stripping voltametry through a
blood lead analysis instrument (3010B; ESA
Laboratories, Inc., Chelmsford, MA, USA)
after the blood samples were digested with an
organic tissue solubilizer. The limit of detec-
tion was 1.0 µg/dL. No detectable values were
given values of 0.70 (1.0 divided by the square
root of 2). Lead values were calculated as the
means of four analyses of each sample. 
Covariates. Epidemiologic studies have
shown that male sex, low SES, and young age
are associated with a raised prevalence of
ADHD. Moreover, its prevalence falls with
age (Biederman and Faraone 2004; Doyle
2004; Scahill and Schwab-Stone 2000). To
address these important confounding factors,
we employed a pair-match design on age, sex,
and SES; thus, the stratiﬁed control subjects
were at risk at the same sex, age, and SES.
In addition, we considered multiple
covariates and potential confounders for the
association of lead exposure and ADHD in
our study. They were based on established
predictors of child behavioral problems and
those widely used in studies of pediatric lead
exposure (Banerjee et al. 2007; Biederman
and Faraone 2005; Linnet et al. 2003; Mick
et al. 2002; Millichap 2008; St Sauver et al.
2004; Swanson et al. 2007; Wasserman et al.
2001). The following variables were used:
family history of ADHD (ADHD in parents
and siblings, diagnosed by psychiatrists,
obtained from clinical reports), household
composition (normal: child lives with biologi-
cal parents; single: child lives with only one
parent; or recombined: child lives in remar-
ried family), maternal tobacco use during
pregnancy (at least one cigarette per day
Wang et al.
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Table 1. Mean values of BLL of ADHD cases and controls.
BLL (μg/dL) (mean ± SE) Percent Percent
Group Total (n = 630) Male (n = 434) Female (n = 196) > 5 μg/dL > 10 μg/dL
ADHD 8.77 ± 3.89 8.89 ± 4.0 8.67 ± 4.17 75.8 24.4
Control 5.76 ± 3.39 5.86 ± 3.44 5.55 ± 3.21 49.8 10.1
t-Value, χ2 t = 14.6 t = 11.96 t = 8.30 χ2 = 237 χ2 = 116
p-Value < 0.05 < 0.05 < 0.05 < 0.01 < 0.01
Figure 1. (A) Blood lead distribution (%) of ADHD cases and controls. (B) Cumulative distribution (%) of
blood lead for ADHD cases and controls.
18
16
14
12
10
8
6
4
2
0
P
e
r
c
e
n
t
 
o
f
 
s
a
m
p
l
e
 
s
i
z
e
02468 1 0 1 2 1 4 1 6 1 8 2 0 2 2 2 4 2 6
Blood lead level (μg/dL)
C
u
m
u
l
a
t
i
v
e
 
p
e
r
c
e
n
t
 
o
f
 
s
a
m
p
l
e
 
s
i
z
e
100
80
60
40
20
0
02468 1 0 1 2 1 4 1 6 1 8 2 0 2 2 2 4 2 6
Blood lead level (μg/dL)
ADHD
Control
ADHD
Control
A Bduring the last trimester), maternal drinking
during pregnancy (at least two glasses per
week during the entire pregnancy), labor
complications, cesarean delivery, perinatal
distress [low birth weight and admission to a
neonatal intensive care unit (NICU) as mark-
ers], parents’ age at childbirth, and parents’
education. Because all the cases recruited were
of Chinese Han nationality, the variable of
ethnic origin could not be used in our analy-
sis. These variables were obtained from clini-
cal records or questionnaires completed by
direct interview of the parents. 
Study factors were deﬁned as binary vari-
ables or categorical variables. For example,
maternal smoking and drinking habits during
pregnancy were recorded as binary vari-
ables—that is, drinker or nondrinker, ciga-
rette smoker or nonsmoker. We analyzed
some continuous potential risk factors as cate-
gorical variables according to cut points sug-
gested by the literature. For example, low
birth weight is typically deﬁned as < 2,500 g
(St Sauver et al. 2004). Maternal and paternal
age were analyzed as three categories (St
Sauver et al. 2004): < 20 years, 20–30 years,
and > 30 years of age. Maternal and paternal
education were analyzed as ≤ 9 years of com-
pulsory education, high school education
(9–12 years), or some college or advanced
training (≥ 12 years).
Data analysis. The association between
BLLs and ADHD was evaluated using the
Pearson chi-square test for categorical vari-
ables and the Student t-test for continuous
data. We also performed a conditional logistic
regression analysis with a binary outcome of
ADHD in relation to BLLs, adjusting for
other potential confounding factors (Hosmer
and Lemeshow 2000). In the regression model,
BLLs were analyzed as an ordered categorical
variable and recorded as three categories:
≤ 5 µg/dL, 5–10 µg/dL, and ≥ 10 µg/dL. We
then performed a conditional logistic regres-
sion analysis with backward stepwise pro-
cedures based on the maximum partial
likelihood estimates to construct a ﬁnal best-
fit logistic regression models to identify pre-
dictors of risk for ADHD among known risk
factors and BLLs. We estimated odds ratios
(ORs) and 95% conﬁdence intervals (CIs) for
differing levels of exposure. All statistical tests
were considered to be signiﬁcant at an alpha
level of 0.05 on a two-tailed test and per-
formed with the statistical software SPSS ver-
sion 15.0 (SPSS Inc., Chicago, IL, USA).
Results 
The analysis included 630 ADHD cases and
630 non-ADHD control subjects matched by
age, sex, and SES. There were 434 sets of
boys and 196 sets of girls. The average ages
were 7.9 ± 2.1 years. The mean BLLs were
8.77 ± 3.89 µg/dL in the ADHD group and
5.76 ± 3.39 µg/dL in the control group. The
ADHD group had higher BLLs (p < 0.05, see
Table 1). There was no signiﬁcant difference
in BLLs between males and females. 
Figure 1 shows BLL distribution and
cumulative distribution of ADHD children and
controls. Only 10.1% of non-ADHD children
had BLLs > 10 µg/dL, whereas this percentage
increased significantly to 24.4% in ADHD
children. (χ2 = 237, p < 0.01). In addition,
49.8% of non-ADHD children had BLLs
> 5 µg/dL, whereas of the ADHD cases, 74.7%
had BLLS > 5 µg/dL (χ2 = 116, p < 0.01).
Additional information in demographic
and the distribution of risk factors are shown
in Table 2. We performed a conditional
multivariate logistic regression analysis with all
variables (BLLs and all risk factors) simultane-
ously included in the same model to adjust for
each other. We found that the ADHD cases
were signiﬁcantly associated with higher BLLs
(OR = 5.19, p < 0.01 for children with BLLs
5–10 µg/dL; OR = 7.15, p < 0.01 for with
BLLs ≥ 10 µg/dL, using the sample with BLLs
≤ 5 µg/dL as referent) and family history
of ADHD (OR = 4.54, p < 0.01, compared
with the sample without familial ADHD his-
tory). The risk for ADHD decreased as the
mother’s education level increased (OR =
0.69, p = 0.017, using the sample of ≤ 9 years
maternal education as referent). The analysis
also found an association between ADHD and
maternal smoking during pregnancy, but
the p-value is near the significant threshold
Attention deficit hyperactivity disorder and blood lead levels
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Table 2. Demographic and distribution of risk factors of ADHD cases and controls.
Characteristic ADHD (n = 630) Controls (n = 630) ORa p-Valuea
Matched factors
Age (years)
4–6 172 172 — —
7–9 303 303
10–12 155 155
Sex 
Male 434 434 — —
Female 196 196
SES (PIR) 
≤ 15 8 5 8 — —
1–3 436 436
≥ 3 136 136
Child factors
Blood lead (μg/dL)
≤ 5 101 316
5–10 326 255 5.19 < 0.01
≥ 10 203 59 7.15 < 0.01
Household composition
Two parent Referent Referent
Single parent 27 23 1.05 0.89
Recombined 15 17 0.50 0.11
Low birth weight (< 2,500 g) 55 64 0.68 0.13
Twin 4 10 0.29 0.08
Family history of ADHD  21 4 4.54  0.02
Pregnancy, labor, or delivery characteristics
Labor or delivery complications 58 70 0.71 0.16
Surgical procedure required  59 67 0.63 0.06
Premature labor  27 22 0.84 0.65
NICU required  39 45 0.57 0.08
Parental factors
Age of mother (years)
≤ 20 81 65
20–30 461 459
≥ 30 88 106 0.92 0.75
Age of father (years)
≤ 20 20 16
20–30 479 493
≥ 30 131 121 1.15 0.41
Maternal education (years)
≤ 9 154 127
9–12 393 371
≥ 12 83 132 0.69 0.017
Paternal education (years)
≤ 9 123 103
9–12 373 376
≥ 12 134 151 1.07 0.97
Maternal drinking during pregnancy 11 6 1.20 0.77
Maternal smoking during pregnancy 6 9 4.04 0.047
—, no data.
aObtained from the multivariate logistic regression model that simultaneously included all the risk factors and the BLLs.(OR = 4.04, p = 0.047). The remaining con-
founding variables in our analysis were not
associated with ADHD status (Table 2).
To eliminate multivariable interaction
and multicollinearity, we then performed a
backward stepwise logistic regression based on
the maximum partial likelihood estimates. In
the final best-fit model, the association
between ADHD and maternal smoking dur-
ing pregnancy was excluded, but ORs for the
associations between ADHD and family his-
tory of ADHD, maternal education levels,
and BLLs were largely unchanged from esti-
mates obtained in the original model used in
Table 2 (Table 3).
We also performed a conditional multi-
variate stepwise logistic regression analysis
stratified by sex and age. As with the total
sample, ADHD cases were signiﬁcantly asso-
ciated with higher BLLs than the lower BLLs
in all subdefinitions (Table 4), which indi-
cates that increased risk for ADHD associated
with BLLs is not modiﬁed by age and sex.
Discussion
We examined the effect of BLLs in ADHD
cases and non-ADHD controls with adjust-
ment for most other known risk factors in
Chinese children 4–12 years of age. We
found ADHD cases were more likely to have
been exposed to lead. The children with BLLs
> 10 µg/dL had 4.1- to 8.7-fold higher risk
for ADHD. Even when their BLLs were
under the recommended level but > 5 µg/dL,
the risk also showed a 3.5- to 7.0-fold
increase. Family history of ADHD was
another positive high-risk factor. Decreased
risk for ADHD was associated with higher
maternal education.
Lead may play important roles in the etiol-
ogy of ADHD. Recently, Braun et al. (2006)
analyzed data from a U.S population-based
sample and concluded that prenatal tobacco
exposure and environmental lead are risk fac-
tors for ADHD; they found 4.1-fold increased
odds of ADHD with increased BLLs. Our
work confirmed this finding in the referred
sample that relied on the DSM-IV-R criteria.
In addition, Nigg et al. (2008) reported that
low-level lead exposure was associated with for-
mal clinical diagnostic ADHD by DSM-IV-R
criteria in a community sample in the United
States, where regulations have reduced the inci-
dence of lead poisoning and the current popu-
lation average of lead levels is relatively lower.
This is consistent with our ﬁnding that the risk
of ADHD was associated with low lead expo-
sures (< 10 µg/dL) in Chinese children. Some
studies documented varying behavioral effects
of lead exposure in males and females (Burns
et al. 1999; Ris et al. 2004). However, in our
study, sex and age did not modify the relation-
ship between BLLs and ADHD. Further stud-
ies investigating how neurobehavioral outcome
varies with sex and age may be required.
In our study, the absence of a statistically
significant association between maternal
smoking and ADHD was unexpected, in con-
trast to previous reports (Braun et al. 2006;
Linnet et al. 2003; Swanson et al. 2007). The
reason might be that, in China, few women
smoke during pregnancy and throughout life,
which limits the statistical power in detecting
a signiﬁcant difference. Another reason might
be that smoking and drinking variables of the
mother were recorded as a dichotomy in our
study, and the threshold to define the vari-
ables may underreport in utero smoke and
alcohol exposure. This potential misclassiﬁca-
tion might underestimate the true association
between pregnancy smoking and ADHD.
Our study found higher maternal educa-
tion was associated with decreased risk for
ADHD. This result is consistent with previ-
ous work, which indicated that low maternal
education, low SES, and single parenthood
are important adverse factors for ADHD
(Biederman and Faraone 2005; Millichap
2008; St Sauver et al. 2004). Apart from envi-
ronmental risk factors for ADHD, our cur-
rent report indicated that children with a
family history of ADHD were more likely to
be diagnosed with ADHD. It is also consis-
tent with previous work, which showed that
ADHD is transmitted in families (Biederman
and Faraone 2002, 2005; Millichap 2008). 
Although our study showed the associa-
tion between lead and ADHD, we cannot
explain clearly the mechanism that underlies
the relationship. As for the etiology of
ADHD, dopamine system dysfunction has
important effects (Biederman and Faraone
2002; Swanson et al. 2007). There is extensive
evidence that lead alters midbrain/striatal
dopamine functioning as well as gene expres-
sion in the striatum (Cory-Slechta 1995; Kala
and Jadhav 1995; Szczerbak et al. 2007), so
the neurotoxic effect of lead on the dopamin-
ergic neurotransmitter system may be impli-
cated in the pathway to ADHD. Lead
exposure could represent a hidden major effect
Wang et al.
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Table 3. Risk factors identiﬁed in stepwise logistic regression model.a
Variables  βb SE Wald test p-Value ORc (95% CI)
BLL
≤ 5
5–10 1.59 0.18 79.86 < 0.01 4.92 (3.47–6.98)
≥ 10 1.79 0.19 85.79 < 0.01 6.00 (4.11–8.77)
Family history of ADHD 1.73 0.63 7.51 < 0.01 5.65 (1.64–19.46)
Maternal education (years)
≤ 9
9–12 –0.13 0.17 0.60 0.438 0.88 (0.63–1.23)
≥ 12 –0.49 0.19 6.90 < 0.01 0.62 (0.43–0.88)
aVariable(s) entered on step 1: BLLs, household composition, birth weight, twin, family history of ADHD, labor complica-
tions, cesarean, premature labor, NICU, mother’s age, father’s age, maternal education, paternal education, prenatal
tobacco exposure and prenatal alcohol exposure. bβ values are the estimated unstandardized regression coefficients.
cOR indicates likelihood of an ADHD.
Table 4. Increased risks for ADHD associated with BLLs in different sample deﬁnitions.
BLL (μg/dL) OR (95% CI) p-Value
Total sample (n = 1,260)
≤ 51 —
5–10 4.92 (3.47–6.98) < 0.01
≥ 10 6.00 (4.11–8.77) < 0.01
Male sample (n = 868)
≤ 51 —
5–10 4.49 (2.97–6.80) < 0.01
≥ 10 6.69 (4.20–10.67) < 0.01
Female sample (n = 392)
≤ 51 —
5–10 5.62 (2.79–11.0) < 0.01
≥ 10 7.38 (3.66–14.88) < 0.01
Age 4–6 years sample (n = 344)
≤ 51 —
5–10 6.86 (3.17–14.86) < 0.01
≥ 10 13.41 (5.04–35.69) < 0.01
Age 7–9 years sample (n = 606)
≤ 51 —
5–10 5.78 (3.33–10.00) < 0.01
≥ 10 8.53 (4.72–15.422) < 0.01
Age 10–12 years sample (n = 310)
≤ 51 —
5–10 3.89 (1.82–8.32) < 0.01
≥ 10 4.13 (2.01–8.49) < 0.01
This table is obtained from the multivariate logistic regression model that simultaneously included all the risk factors and
the BLL. OR indicates likelihood of ADHD. on ADHD incidence via genotype by environ-
mental interaction (Swanson et al. 2007). 
Strengths of the study. The strengths of
this study are as follows: a) Our sample size
was the largest to date in case–control studies
to investigate BLLs and ADHD. b) The
ADHD diagnosis was made through an
extensive clinical evaluation based on the
DSM-IV-R diagnostic instrument and per-
formed by child and adolescent psychiatrists.
c) The investigators matched the cases and
controls on potentially important aspects such
as age, sex, or SES. This is important because
lead levels are highest among younger chil-
dren compared with adolescents, and ADHD
is of higher prevalence among children of ele-
mentary and middle-school age. 
Clinical implications. This study suggests
that there is a link between ADHD and
BLLs, and the results reinforced ﬁndings from
previous studies (Braun et al. 2006; Nigg
et al. 2008). If on further inquiry these associ-
ations are found to be causal, lead exposure
may represent a modiﬁable risk factor for this
common psychiatric condition of childhood.
Considering that ADHD typically starts in
early childhood and that lead poisoning is one
of the most common and entirely preventable
pediatric problems (AAP 2005; CDC 1991),
strategies in public health must focus on prac-
ticing primary and secondary prevention of
lead exposure in children. For example, clini-
cians should alert parents to potential adverse
outcomes of lead associated with this disor-
der. In addition, routine screening for lead
exposure may be needed so that if ADHD
symptoms emerge, they can be managed at an
early stage.
Moreover, BLLs < 10 µg/dL also indi-
cated a risk factor. This may suggest that the
lower standard may effectively protect chil-
dren from the harmful effects of lead, which
is consistent with previous investigations
(AAP 2005; Canfield et al. 2003; Surkan
et al. 2007).
Some studies (Ruff et al. 1993; Tong et al.
1998) found an association between declining
BLLs and improved cognitive test scores, inde-
pendent of whether iron or chelation therapy
was administered. However, other works
(AAP 2005; Canfield et al. 2003) indicated
that the damage caused by blood lead expo-
sure is irreversible. Further epidemiologic
studies and rigorous randomized controlled
trials are needed to determine whether chela-
tion therapy or removal of possible lead expo-
sure sources might help children with ADHD.
Limitations. This study has several limita-
tions. First, temporality between high BLLs
and ADHD could not be ascertained deﬁnitely
in this case–control design. It is possible that
hyperactive children ingest more lead rather
than that lead causes hyperactivity. Therefore,
further studies with serial lead measurements,
even from the antenatal to the postnatal
period, and more continuous measures of
ADHD symptoms or of specific underlying
neurobehavioral domains may be required to
document the temporal relationship between
lead exposure and development of ADHD.
Second, some might argue that concurrent
blood lead tests are not an adequate biomarker
of a child’s lifetime exposure. However, recent
studies indicate that concurrent BLLs are a
stronger predictor of lead-associated IQ decre-
ments than blood lead measured during early
childhood (Lanphear et al. 2005). Third, recall
bias is one of the problems of the case–control
study. In this study, the main variable of inter-
est was the BLLs, which were objectively
measured. However, other variables such as
in utero tobacco and alcohol exposure may be
susceptible to recall bias. Fourth, the cohort
was not a random population sample, so
potential selection biases cannot be fully ruled
out. In addition, because all our sample was
Chinese Han, no children living in foster fami-
lies were included, and none of the sample had
health insurance, our results may not generalize
to children with different socioeconomic or
ethnic backgrounds. Finally, it is interesting
that Nigg et al. (2008) found a signiﬁcant rela-
tionship between combined-type ADHD and
low-level lead exposure but not predominantly
inattentive type and lead exposure. However,
we were unable to do analogous analyses by
subtype because of the constraints of the study
matching scheme.
Conclusions 
This hospital-based case–control study suggests
a strong relationship exists between ADHD
and lead exposure, even low-level lead exposure
(< 10 µg/dL BLL), in Chinese children. If this
finding is confirmed in future studies, the
potential to prevent ADHD by reducing child-
hood lead exposure should be considered.
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